References
- GSK completes Consumer Healthcare buyout. www.gsk.com/en-gb/media/press-releases/gsk-completes-consumer-healthcare-buyout/
- AbbVie to acquire Allergan in transformative move for both companies.https://news.abbvie.com/news/press-releases/abbvie-to-acquire-allergan-in-transformative-move-for-both-companies.htm
- Amgen and the Institute For Protein Design (IPD) at University Of Washington announce unique strategic research partnership.www.amgen.com/media/news-releases/2019/06/amgen-and-the-institute-for-protein-design-ipd-at-university-of-washington-announce-unique-strategic-research-partnership/
- Merck to acquire Tilos Therapeutics.www.mrknewsroom.com/news-release/research-and-development-news/merck-acquire-tilos-therapeutics.
- Simpson I . Industry update covering October. Ther. Deliv.10(2), (2018). https://doi.org/10.4155/tde-2018-0071
- www.novartis.com/news/media-releases/new-sandoz-biosimilar-adalimumab-data-confirmsswitching-from-reference-biologic-has-no-impact-safety-or-efficacy
- Cohen HP , BlauveltA , RifkinRMet al. Drugs 78, 463 (2018). https://doi.org/10.1007/s40265-018-0881-y
- Novartis presents first-of-its-kind histology data with iscalimab (CFZ533) suggesting the extended survival of transplanted organs may be possible.www.novartis.com/news/media-releases/novartis-presents-first-its-kind-histology-data-iscalimab-cfz533-suggesting-extended-survival-transplanted-organs-may-be-possible.
- 632 - CNI-free therapy with iscalimab (anti-CD40 mAb) preserves allograft histology compared with standard of care after kidney transplantation. https://eventpilotadmin.com/web/page.php?page=IntHtml&project=ATC19&id=2067
- Intec Pharma announces results from earlier Phase 2 clinical trial of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's disease patients published in Parkinsonism and related disorders. www.intecpharma.com/technology/
- https://ir.intecpharma.com/news-releases/news-release-details/intec-pharma-announces-results-earlier-phase-2-clinical-trial
- Navon A . The Accordion Pill: unique oral delivery to enhance pharmacokinetics and therapeutic benefit of challenging drugs. Ther. Deliv.10(7), (2018). https://doi.org/10.4155/tde-2018-0067
- Nucala (mepolizumab) gains FDA approval for two new self-administration options.www.gsk.com/en-gb/media/press-releases/nucala-mepolizumab-gains-fda-approval-for-two-new-self-administration-options/
- www.roche.com/media/releases/med-cor-2019-06-18.htm
- bluebird bio announces EU conditional marketing authorization for ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) gene therapy for patients 12 years and older with transfusion-dependent β-thalassemia who do not have β0/β0 genotype.http://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-announces-eu-conditional-marketing-authorization
- Bluebird prices gene therapy Zynteglo at €1.575M in Europe, to be paid over 5 years.www.fiercepharma.com/pharma/bluebird-prices-gene-therapy-zynteglo-at-eu1-575m-europe-to-be-paid-over-5-years
- Breztri Aerosphere (PT010) approved in Japan for patients with chronic obstructive pulmonary disease.www.astrazeneca.com/content/astraz/media-centre/press-releases/2019/breztri-aerosphere-pt010-approved-in-japan-for-patients-with-chronic-obstructive-pulmonary-disease-19062019.html
- Trani ND , SilvestriA , BrunoGet al. Remotely controlled nanofluidic implantable platform for tunable drug delivery. Lab Chip19, 2192 (2019) doi:10.1039/C9LC00394K ( Epub ahead of print).
- Hashemnejad SM , BadruddozaAZM , ZarketBet al. Thermoresponsive nanoemulsion-based gel synthesized through a low-energy process. Nat. Commun.10, 2749 (2019) doi:10.1038/s41467-019-10749-1 ( Epub ahead of print).
- ‘Nanoemulsion’ gels offer new way to deliver drugs through the skin.http://news.mit.edu/2019/nanoemulsion-gels-skin-drugs-0621